e-learning
resources
Stockholm 2007
Monday 17.09.2007
Environmental and clinical aspects of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Changes in COPD-related morbidity and mortality after smoking cessation: a review
N. S. Godtfredsen, T. Hansel, T. H. Lam, E. Prescott, P. Lange, J. Vestbo (Hellerup, Copenhagen, Hvidovre, Denmark; London, United Kingdom; Hong Kong, China)
Source:
Annual Congress 2007 - Environmental and clinical aspects of COPD
Session:
Environmental and clinical aspects of COPD
Session type:
Electronic Poster Discussion
Number:
1911
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. S. Godtfredsen, T. Hansel, T. H. Lam, E. Prescott, P. Lange, J. Vestbo (Hellerup, Copenhagen, Hvidovre, Denmark; London, United Kingdom; Hong Kong, China). Changes in COPD-related morbidity and mortality after smoking cessation: a review. Eur Respir J 2007; 30: Suppl. 51, 1911
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
COPD-related morbidity and mortality after smoking cessation: status of the evidence
Source: Eur Respir J 2008; 32: 844-853
Year: 2008
Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis
Source: Eur Respir Rev, 29 (156) 190166; 10.1183/16000617.0166-2019
Year: 2020
Smoking Cessation, the most cost effective intervention for the most preventable mortality and morbidity burden
Source: International Congress 2017 – Hot topic on tobacco prevention and cessation
Year: 2017
Gender differences in mortality risks in relation to smoking in a long-term follow-up of the Malmö preventive project
Source: Eur Respir J 2003; 22: Suppl. 45, 111s
Year: 2003
Contribution of respiratory disease and smoking to in-hospital mortality
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
In-hospital smoking cessation intervention
Source: Eur Respir J 2006; 28: Suppl. 50, 391s
Year: 2006
Changes in physical activity and all-cause mortality in COPD
Source: Eur Respir J 2014; 44: 1199-1209
Year: 2014
Relationship between mortality risk and health status in COPD
Source: Annual Congress 2009 - Are outcome measures useful to predict success in rehabilitation and the care of patients with chronic respiratory disease
Year: 2009
Level of FEV1 as a predictor of all-cause and cardiovascular mortality: an effect beyond smoking and physical fitness?
Source: Eur Respir J 2005; 25: 587-588
Year: 2005
Predictors of mortality in COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
Predictors of mortality in COPD
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
Influence of maternal active smoking on childhood asthma morbidity
Source: Eur Respir J 2005; 26: Suppl. 49, 157s
Year: 2005
Gender differences between number of hospital admissions related to smoking and low FEV
1
in a long-term follow-up -the Malmö prevention project
Source: Eur Respir J 2002; 20: Suppl. 38, 514s
Year: 2002
Long-term impact of COPD on postoperative cardiorespiratory morbidity and mortality: a population cohort study
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021
The impact on risk-factor analysis of different mortality outcomes in COPD patients
Source: Eur Respir J 2008; 32: 629-636
Year: 2008
Is cardiovascular co-morbidity increasing success rate of smoking cessation at respiratory disorders inpatients?
Source: Annual Congress 2007 - Smoking cessation
Year: 2007
Weighted smoking score: Measuring the benefits of quitting smoking in COPD
Source: International Congress 2016 – New approaches and finding in smoking cessation
Year: 2016
Success rate of a trans-disciplinary in-hospital smoking cessation program
Source: Annual Congress 2013 –Smoking cessation
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept